Search

Search Constraints

You searched for: Author/Creator Conklin, John

Search Results

2. 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus. (14th December 2022)

3. 616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities. (14th December 2022)

5. A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus. Issue 1 (12th July 2021)

6. A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus. Issue 2 (4th February 2021)

7. An artificial intelligence‐accelerated 2‐minute multi‐shot echo planar imaging protocol for comprehensive high‐quality clinical brain imaging. Issue 5 (31st December 2021)

9. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

10. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)